Alphatec plunges 37% after cutting full-year outlook
FROM THE WIRE · FINANCE.YAHOO.COM
Alphatec slashes its full-year outlook as fewer surgeons have purchased its add-on bone-graft products used for spinal fusion. Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe full-year outlook cut weighs on a spinal surgery device maker's stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Alphatec slashes its full-year outlook.
- 02Fewer surgeons have bought its add-on bone-graft products.
- 03The bone-graft products are used for spinal fusion.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets